ESPX:CA:TSX-Evolve S&P 500® Enhanced Yield Fund CAD Hedged (CAD)

ETF | Others |

Last Closing

CAD 24.97

Change

+0.07 (+0.28)%

Market Cap

CAD 0.08B

Volume

500.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.16 (-0.56%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.37B
PHYS-U:CA Sprott Physical Gold Trust

-0.15 (-0.73%)

CAD 4.76B
XEQT:CA iShares Core Equity Portfolio

-0.06 (-0.19%)

CAD 4.70B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.06 (-0.17%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.02 (+0.04%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.24 (+2.29%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.04 (-0.17%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing ESPX:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.99% 62% D 58% F
Dividend Return 0.70% 53% F 22% F
Total Return 13.69% 64% D 55% F
Trailing 12 Months  
Capital Gain 21.45% 61% D- 61% D-
Dividend Return 0.75% 50% F 17% F
Total Return 22.20% 61% D- 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.85% 70% C- 55% F
Dividend Return 4.98% 70% C- 51% F
Total Return 0.13% 58% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 6.28% 62% D 83% B
Risk Adjusted Return 79.31% 93% A 89% A-
Market Capitalization 0.08B 59% D- 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike